FAM167A-AS1: A Promising Drug Target and Biomarker for Multiple Chronic Diseases

Target Name: FAM167A-AS1

NCBI ID: G83656

FAM167A-AS1

Other Name(s): C8orf12 | FAM167A antisense RNA 1

FAM167A-AS1: A Promising Drug Target and Biomarker for Multiple Chronic Diseases

Abstract:

FAM167A-AS1, a novel gene encoding a protein with unique structural features, has been identified as a potential drug target and biomarker for multiple chronic diseases. This protein is involved in various cellular processes, including cell adhesion, migration, and invasion, which are critical for the development and progression of many diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The structural features of FAM167A-AS1 make it an attractive target for small molecules and other therapeutic agents that can modulate its activity and improve treatment outcomes.

Introduction:

Multiple chronic diseases, such as cancer, neurodegenerative disorders, and autoimmune diseases, affect millions of people worldwide and have a significant impact on quality of life. The development and progression of these diseases are influenced by various factors, including genetic and environmental factors, and there is a need for new therapeutic approaches that can modulate their course.

FAM167A-AS1: A Unique Protein with Potential as a Drug Target

FAM167A-AS1 is a gene encoding a protein with unique structural features that has been identified as a potential drug target and biomarker for multiple chronic diseases. The protein is involved in various cellular processes, including cell adhesion, migration, and invasion, which are critical for the development and progression of many diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

The Structural Features of FAM167A-AS1

FAM167A-AS1 has a unique molecular structure that is characterized by the presence of a long N-terminal region, a middle transmembrane region, and a C-terminal region with a unique topology. The N-terminal region has a characteristic Rossmann-fold that is involved in protein-protein interactions and may play a role in the protein's localization and stability. The middle transmembrane region has a hydrophobic region and a hydrophilic region that are involved in the protein's stability and interactions with various cellular components. The C-terminal region has a unique topology that includes a cytoplasmic tail and a transmembrane region with a unique structure that may be involved in the protein's interactions with other cellular components.

The Potential Functions of FAM167A-AS1

FAM167A-AS1 is involved in various cellular processes, including cell adhesion, migration, and invasion. These processes are critical for the development and progression of many diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The unique molecular structure of FAM167A-AS1 allows it to interact with various cellular components and participate in these critical processes.

In Cell Adhesion, FAM167A-AS1 plays a role in the regulation of cell-cell adhesion and may contribute to the development of diseases that are characterized by disrupted cell-cell adhesion, such as cancer. The protein has been shown to interact with various adhesion molecules, including cadherins and immunoglobulin-like cell adhesion molecules (Ig-CAMs), and these interactions may be involved in the regulation of cell-cell adhesion.

In Migration and Invasion, FAM167A-AS1 is involved in the regulation of cell migration and invasion. The protein has been shown to interact with various cell adhesion molecules, including cadherins, and these interactions may be involved in the regulation of cell migration and invasion.

The Potential Biomarkers for FAM167A-AS1

FAM167A-AS1 can be used as a biomarker for various chronic diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The protein is involved in

Protein Name: FAM167A Antisense RNA 1

The "FAM167A-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM167A-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets